Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Highresolution Ct Scanning

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01797341Phase 3CompletedPrimary

Prograf-Advagraf Cross Over Conversion Study

NCT01017757Unknown

Interstitial Lung Abnormalities in Renal Transplant Recipients

Showing all 2 trials

Research Network

Common Treatments

  • Highresolution Ct Scanning1
  • Tacrolimus1

Active Sponsors

  • University of Parma1
  • University Health Network, Toronto1

Top Investigators

Related Conditions

  • Renal Transplantation1

Activity Timeline